Copertina

Potential Application of Natural Products in Weight Management and Obesity: Focusing on the Gut Microbiota

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Shiqiong Huang, Zheng Zhou, Gefei He
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Phytotherapy Research
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Phytotherapy for Obesity Management: The Role of Gut Microbiota in Reshaping Adipose Tissue
di: Huiyang Wang, et al.
Pubblicazione: (2025)

Potential Candidates of Natural Antioxidants From Herbs for Treating Lung Disorders: Focus on Redox Balance and Natural Products
di: Xing Chang, et al.
Pubblicazione: (2025)

Chlorogenic Acid Ameliorates Lipid Metabolism Disorders via Gut Microbiota‐Serum Metabolite‐Liver Axis in High‐Fat Diet‐Induced Obesity
di: Zhineng Wang, et al.
Pubblicazione: (2026)

Hypoglycemic Effect of Ginsenoside Compound K Mediated by N‐Acetylserotonin Derived From Gut Microbiota
di: Su‐Tian‐Zi Huang, et al.
Pubblicazione: (2025)

Dietary Polyphenols in Metabolic Diseases: Roles of Gut Microbiota‐Derived Metabolites
di: Pengzhao Tang, et al.
Pubblicazione: (2026)

Gut Microbiota and Bile Acid Metabolism in the Mechanism of Ginsenoside Re Against Nonalcoholic Fatty Liver Disease
di: Yanfang Zheng, et al.
Pubblicazione: (2025)

Piperine Improves DSS‐Induced Colitis in Mice via Inhibition of Inflammation and Modulation of Gut Microbiota
di: Yeye Hu, et al.
Pubblicazione: (2025)

Resveratrol Attenuates Neuroinflammation and Gut–Brain Axis Dysfunction Induced by Lead and Cadmium Co‐Exposure by Modulating Gut Microbiota in Rats
di: Huimao Liu, et al.
Pubblicazione: (2026)

Ferulic Acid Alleviates Traumatic Brain Injury and Gastrointestinal Disorders by Promoting Ghrelin to Regulate the Microbiota‐Brain‐Gut Axis Inflammation and Pyroptosis
di: Yawen Cai, et al.
Pubblicazione: (2025)

Phytochemicals in MASLD : A Focused Review of Gut Microbiome‐Linked Mechanisms
di: Jeong In Seo, et al.
Pubblicazione: (2026)

Phytochemicals‐Mediated Gut Microbiota Regulation: A Comprehensive Review of Therapeutic Strategies for Cardiovascular Diseases
di: Jianxia Wen, et al.
Pubblicazione: (2026)

Mechanisms and Potential of Antitumor Therapy With Natural Products Regulating Non‐Coding RNAs
di: Zhuguo Wang, et al.
Pubblicazione: (2025)

Asiatic Acid Alleviates Ulcerative Colitis Through a Gut Microbiota‐Driven cAMP / PKA / NF ‐ κB Pathway: γ‐Glutamyltyrosine Is a Crucial Player
di: Xian Zheng, et al.
Pubblicazione: (2025)

Luteolin Treats Obese Rats With Polycystic Ovary Syndrome by Improving Liver Lipid Metabolism and Regulating the Gut Microbiota
di: Guoyu Dai, et al.
Pubblicazione: (2025)

Natural Compounds Exert Anti‐Obesity Effects by Regulating Cytokines
di: Yu Zhang, et al.
Pubblicazione: (2025)

Recent Advances in Natural Products for Cancer Immunotherapy
di: Taiqing Liu, et al.
Pubblicazione: (2026)

Astragaloside IV Exhibited Antidiabetic Effects by Improving Glucose Metabolism, Repairing Damaged Gut Barrier and Regulating Intestinal Microbiota
di: Xiaolei Yang, et al.
Pubblicazione: (2026)

Traditional Chinese Medicine Improves the Development of Vascular Thrombotic Inflammation: The Key Role of Gut Microbiota and Its Derived Metabolites
di: Jingjing Xu, et al.
Pubblicazione: (2025)

Angelica dahurica Polysaccharides Ameliorate Colitis by Reducing the Restriction of Gut Microbiota‐Derived Imidazole Propionate on PPAR‐γ Signaling Activation
di: Jingyi Hu, et al.
Pubblicazione: (2025)

The Potential Mechanism of Soy Isoflavones in Treating Osteoporosis: Focusing on Bone Metabolism and Oxidative Stress
di: Yuanyuan Zhou, et al.
Pubblicazione: (2025)

Zingibroside R1 Isolated From Achyranthes bidentata Blume Ameliorates LPS/D‐GalN‐Induced Liver Injury by Regulating Succinic Acid Metabolism via the Gut Microbiota
di: Pengli Guo, et al.
Pubblicazione: (2025)

Poncirus trifoliata Extract and Its Active Coumarins Alleviate Dexamethasone‐Induced Skeletal Muscle Atrophy by Regulating Protein Synthesis, Mitochondrial Biogenesis, and Gut Microbiota
di: Hyejin Ko, et al.
Pubblicazione: (2025)

Ginsenosides From Panax ginseng Improves Hepatic Lipid Metabolism Disorders in HFD ‐Fed Rats by Regulating Gut Microbiota and Cholesterol Metabolism Signaling Pathways
di: Yue Zhu, et al.
Pubblicazione: (2024)

Unlocking the Therapeutic Potential of Autophagy Modulation by Natural Products in Tackling Non‐Alcoholic Fatty Liver Disease
di: Farshad Niazpour, et al.
Pubblicazione: (2025)

Effect of Puerarin on Chronic Alcoholic Encephalopathy by Modulating the “Microbiota‐Gut‐Brain Axis” Lipopolysaccharides/Toll‐Like Receptors 4/Nuclear Factor Kappa‐B Inflammatory Pathway
di: Lei Zhang, et al.
Pubblicazione: (2026)

Advancements in Osteoarthritis Treatment: The Potential of Natural Herbs in Reducing Inflammation and Cartilage Degeneration
di: Zeyu Peng, et al.
Pubblicazione: (2026)

Natural Products and Exercise Synergy: Unraveling Molecular Mechanisms to Enhance Brain Function in Alzheimer's Disease
di: Long Chen, et al.
Pubblicazione: (2025)

Unlocking Natural Potential: Antibody‐Drug Conjugates With Naturally Derived Payloads for Cancer Therapy
di: Xue Jiang, et al.
Pubblicazione: (2024)

The Role of Polyphenols in Respiratory and Gut Health: From the Perspective of Gut‐Lung Axis
di: Jian Kang, et al.
Pubblicazione: (2026)

Curcumin: A Potential Detoxifier Against Chemical and Natural Toxicants
di: Harsh Kumar, et al.
Pubblicazione: (2025)

Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
di: Lvzhuo Zhang, et al.
Pubblicazione: (2024)

Natural Products as Modulators of ABC Transporters in Breast Cancer
di: Yoganishalini Sagadevan, et al.
Pubblicazione: (2026)

Phytochemicals in Inflammatory Bowel Disease: Targeting Oxidative Stress for Improved Gut Health
di: Junyan Gao, et al.
Pubblicazione: (2026)

Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems
di: Jing Xian, et al.
Pubblicazione: (2024)

Advances in Research on Marine Natural Products for Modulating the Inflammatory Microenvironment
di: Yuru Li, et al.
Pubblicazione: (2025)

Epigenetic Effects of Natural Products in Inflammatory Diseases: Recent Findings
di: Qianyi Yao, et al.
Pubblicazione: (2024)

Polydatin Targets ACADVL to Combat Obesity by Promoting Adipocyte Browning and Activating Fatty Acid Oxidation
di: Wenjun He, et al.
Pubblicazione: (2026)

Targeting Mitochondrial Dysfunction by Natural Products for the Treatment of Diabetic Kidney Disease
di: Jin‐Ling Huo, et al.
Pubblicazione: (2025)

Epigenetic Insights Into Aging: Emerging Roles of Natural Products in Therapeutic Interventions
di: Yutong Pang, et al.
Pubblicazione: (2025)

MicroRNAs for Diabetes Management: From Natural Bioactive Compounds to Nucleotide Networks
di: Junren Chen, et al.
Pubblicazione: (2025)